Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

CompletedOBSERVATIONAL

Enrollment

176

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

MenopausePostmenopausal Bleeding

Interventions

DRUG

0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)

Data collection of the use of 0.5 mg estradiol and 0.1 mg norethisterone acetate (NETA) in women in connection to a daily clinical practice.

Trial Locations (2)

Rud

Gothenburg